ChironX

ChironX deal uses a hybrid stack of complex and proprietary image processing algorithms, in conjunction with classical machine learning techniques. There's a lot of deep learning usage in some of its modules as well. It is a provider of an artificial intelligence-based disease detection platform.

The company employs machine learning and clinical imaging techniques where images can be screened on portable medical devices to diagnose diseases such as oral and cervical cancer. It uses diagnostic software to detect complex diseases from medical images - making it faster, cheaper and more robust and with it, blindness can be preventable. ChironEye, which is a flagship software, analyzes retinal fundus images in seconds.

It detects diabetic retinopathy, hypertensive retinopathy, age-related macular degeneration, diabetic macular edema and a host of other diseases. It annotates lesions and regions of interest, and assists doctors and even non-specialists to arrive at a diagnosis faster and with much higher accuracy. It works with both mydriatic and non-mydriatic images. It's not enough to merely detect diseases; it's important to be able to detect diseases early, rank them for risk and allow doctors to focus on prevention, prognosis, and cure.

AI-based auto diagnostic software; such as ChironX, help doctors work with unprecedented efficiency and confidence. To do this at scale and effectively; it delineates contextual abnormalities reliably and fast - faster than a human could. ChironX moves towards replicating differential diagnosis and risk prediction pathways, and are not only leveraging the world of medicine but also enriching it.